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Abstract. This paper presents a multidistance and multiwavelength diffuse correlation spectroscopy (DCS)
approach and its implementation to simultaneously measure the optical proprieties of deep tissue as well as
the blood flow. The system consists of three long coherence length lasers at different wavelengths in the
near-infrared, eight single-photon detectors, and a correlator board. With this approach, we collect both light
intensity and DCS data at multiple distances and multiple wavelengths, which provide unique information to
fit for all the parameters of interest: scattering, blood flow, and hemoglobin concentration. We present the char-
acterization of the system and its validation with phantom measurements. © The Authors. Published by SPIE under a Creative
Commons Attribution 3.0 Unported License. Distribution or reproduction of this work in whole or in part requires full attribution of the original publication,
including its DOI. [DOI: 10.1117/1.NPh.5.1.011015]
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1 Introduction
Diffuse correlation spectroscopy (DCS) is a relatively new near-
infrared spectroscopy (NIRS) method that is being increasingly
adopted because of its ability to directly measure an index of
microvascular blood flow (BFi). In particular, its utility to mea-
sure cerebral blood flow is now being tested in several clinical
applications.1–3 By employing a long coherence length laser and
photon counting detectors, DCS measures how fast coherent
light loses coherence because of the movement of red blood
cells. The correlation diffusion equation 2,4,5 relates the motion
of red blood cells in vessels to the measured temporal autocor-
relation decay. The correlation diffusion equation in addition to
blood flow also depends on tissue absorption (μa) and reduced
scattering (μ 0s) coefficients. Hence, by fitting the equation to the
measured autocorrelation function, we can derive a quantitative
blood flow index (BFi, cm2∕s)6 only if we know or assume
absorption and scattering. It has been demonstrated that the
cross talk between static (absorption and scattering) and
dynamic (flow) properties of the tissue does not permit fitting
for multiple parameters using a single autocorrelation function.7
To correctly estimate absolute BFi, it is customary to use NIRS
in conjunction with DCS8,9 and to simultaneously quantify
tissue optical properties and BFi. The need for combining two
modalities makes the approach more complex.
A recent study10 demonstrates how both optical properties
and BFi can be estimated with DCS alone by taking advantage
of a multidistance approach. It requires the acquisition of auto-
correlation curves at different source–detector separations (ρ)
and fitting over time delay and ρ. This method can simultane-
ously fit for μa, μ 0s , and BFi, but provides robust estimates only
in the case of short separations (i.e., ρ < 10 mm). While this can
work in rodents and small animals, it is not suitable for human
measurements where separations larger than 10 mm are required
to increase sensitivity to deeper tissues, including cerebral blood
flow through the intact skull.
To overcome this limitation, we conceived an approach that,
in addition to multiple distances, employs DCS at multiple
wavelengths to recover both optical properties and BFi using
large separations (20 to 30 mm). The measurement of the inten-
sity decay over distance provides a slope proportional to the
product μa · μ 0s (the effective attenuation coefficient). The mea-
surements of the decay of the autocorrelation function at three
or more wavelengths provide the remaining information to
uniquely determine reduced scattering, blood flow, and hemo-
globin concentration.
In this paper, we present a DCS system able to simultane-
ously measure optical properties and BFi taking advantage
of the multidistance and multiwavelength (MD-MW) DCS
approach. We have validated the method’s robustness with
tissue-like phantom experiments.
2 Theory and Methods
2.1 Multidistance Multiwavelength Diffuse
Correlation Spectroscopy Method Theory
DCS measures the temporal speckle fluctuations due to the
moving scatterers in tissue (red blood cells), which in turn
could be used to estimate an index of blood flow in the
microvasculature.4,6,11 The dynamic motion of the medium
can be determined by measurement of the autocorrelation func-
tion, as faster motion of the scatterers is indicated by faster
speckle fluctuations (i.e., more rapid decay of the autocorrela-
tion function). The Green’s function solution of the correlation
diffusion equation for semi-infinite boundary conditions8 is
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q
; (4)
zb ¼ 2∕μ 0sð1þ ReffÞ∕ð1 − ReffÞ, Reff is the effective reflection
coefficient to account for the index mismatch between tissue
and air, k0 ¼ 2π∕λ is the wave number of light in the medium,
corrected λ is the light wavelength, τ is the delay time, ρ is the
source–detector separation, BFi is the quantitative blood flow
index, μa and μ 0s are, respectively, the absorption and reduced
scattering coefficients. The blood flow index is historically
described as the probability of a dynamic scattering event (i.e.,
scattering from a red blood cell) times the mean square displace-
ment of the dynamic scatterers (i.e., red blood cells).2,4 We
recently showed that it can be explicitly related to the absolute
blood flow as given by Eq. (15) in Ref. 11, where the probability
of scattering from a red blood cell has a potential wavelength
dependence given by the blood reduced scattering coefficient
divided by the tissue reduced scattering coefficient. This poten-
tial wavelength dependence is negligible as both the blood
and tissue scattering coefficients vary with wavelength in a sim-
ilar way. We therefore ignore this potential wavelength depend-
ence here, but will discuss its potential impact in the discussion
section. Then, in our homogeneous dynamic phantom measure-
ments (described below), the probability of a dynamic scattering
event is equal to 1 and is not wavelength dependent.
DCS measures the normalized intensity autocorrelation
function (g2), while the correlation diffusion equation applies to
the electric field autocorrelation function. To fit the theory to
the experimental data, the normalized intensity autocorrelation
function must be related to the normalized electric field temporal
autocorrelation (g1) through the Siegert relation
12
EQ-TARGET;temp:intralink-;e005;63;283g2ðτ; ρ; λÞ ¼ 1þ βg1ðτ; ρ; λÞ2; (5)
where β is a constant determined primarily by the optics of the
experiment and it is related to the number of modes in the
detected light. In most DCS experiments, employing coherent,
nonpolarized sources, and single mode detector fibers, β is
∼0.5.13
We aim to decouple the contribution of static (absorption and
scattering) and dynamic (flow) properties of the tissue at large
separations, which enables us to simultaneously estimate BFi,
hemoglobin oxygenation (SO2), and oxygenated and deoxygen-
ated hemoglobin concentrations (HbO and HbR, respectively).
To this end, assuming a homogeneous medium, we use the DCS
information (light intensity and g2 curves) obtained from multi-
ple wavelengths at multiple source–detector separations to fit for
the desired parameters (μa, μ 0s , and BFi).
By measuring the light intensity at each separation and wave-
length, Iðρ; λÞ, and by calibrating sources and detectors, for each
wavelength, we obtain the effective attenuation coefficient
EQ-TARGET;temp:intralink-;e006;326;752μeffðλÞ ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
3μ 0sðλÞ · μaðλÞ
p
; (6)
since μeffðλÞ is given by the slope of the simplified solution of
the diffusion equation8 versus distance
EQ-TARGET;temp:intralink-;e007;326;706 ln½ρ2Iðρ; λÞ ¼ −μeffðλÞρþ I0ðρ ¼ 0; λÞ: (7)
To aid convergence of the fitting algorithm, we apply addi-
tional constrains. First BFi is constant over wavelengths, since
flow is a mechanical property of the medium and does not
depend on the wavelength used to perform the measurement.
Then, we take into account the wavelength dependence of μ 0s
and μa. The reduced scattering coefficient in tissue follows
an empirical power law relationship:14–18
EQ-TARGET;temp:intralink-;e008;326;597μ 0sðλÞ ¼ aλ−b; (8)
where a is the scaling factor and b is the scattering power,
both independent from λ. The absorption coefficient in tissues
linearly depends on the hemoglobin concentrations as
EQ-TARGET;temp:intralink-;e009;326;533
μaðλÞ ¼ ϵHbOðλÞ ·HbOþ ϵHbRðλÞ ·HbRþpH2O · μaðH2OÞðλÞ;
(9)
where ϵðλÞ is the wavelength-dependent oxy- and deoxy-hemo-
globin extinction coefficients, obtained from the literature,19 and
pH2O is the assumed percent of water in tissue.
20,21
The MD-MW DCS global fitting is performed to fit exper-
imental data over λ, τ, and ρ to minimize the cost function (χ2) to




















where γ is a scaling factor that changes the weight of μeff in the
fitting procedure. When γ ¼ 0, the fitting discards the informa-
tion from intensity and the fitted μeff does not necessarily match
the measured μeff . By increasing γ toward higher values, we are
enforcing the fitted μeff to match the measured one. The optimal
γ depends on the relative noise levels in the intensity and auto-
correlation function data. For our system and experiments, γ
between 0.05 and 0.5 provides the best estimates of the optical
properties and BFi. We used γ ¼ 0.3 for the phantom experi-
ment results presented below.
Finally, from the five fitted parameters, we can calculate
μ 0s and μa at each wavelength using Eqs. (8) and (9), as well
as the total hemoglobin concentration (HbT ¼ HbOþ HbR)
and oxygenation (SO2 ¼ HbO∕HbT).
2.2 Methods
We validated the MD-MWDCS approach with measurements in
tissue-like phantoms.
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We used liquid mixtures of water, Intralipid, and black India
ink to increase the absorption or scattering of the solution at
regular increments. For the absorption titrations, we mixed
40 ml of 20% Intralipid suspension in 1600 ml of water to
achieve a scattering coefficient of 5.5 cm−1 at 808 nm. There
was initially no absorption (beyond the water itself), and
progressive amounts of diluted India ink were added to increase
optical absorption to 450% of the initial value. For the scattering
titrations, we started by mixing 20% Intralipid with water and
India ink to achieve an absorption of about 0.03 cm−1 at
808 nm. Additional amounts (8 ml) of concentrated Intralipid
were added until scattering increased by 150% of the initial
value. The liquid mixture was stirred using a magnetic stirrer
after every ink or Intralipid step, and it was allowed to come
to rest before taking a measurement, about 2 min (monitored
by following the return of the DCS autocorrelation function
to a stable value). To simulate blood flow changes, we used
the same stirrer and left it on at different levels during the mea-
surements to increase the dynamics of the liquid phantom. For
simplicity in this article, we call BFi the mean square displace-
ment of the scattering particles within the solution. For these
measurements, we used a silicone oil-based solution, much
more viscous than the water, and the Intralipid/India ink solu-
tions were used for the absorption and scattering titrations. This
silicon-based solution allowed us to perform measurements at
nine stirring levels and increase BFi by 1400% from the initial
value.
All measurements were done at a constant temperature of
20°C (changes in temperature affect the Brownian motion of
the solution). At each titration step, measurements were done
for 20 s per wavelength with the MD-MWDCS system. In addi-
tion to the measurements at the three MD-MW DCS wave-
lengths (767, 808, and 852 nm), we used an additional laser
at 785 nm (CL-2000 diode pumped crystal, by CrystaLaser)
to check potential improvements using four wavelengths.
The recovered optical properties were compared to the optical
properties simultaneously measured with a commercial fre-
quency-domain near-infrared spectroscopy (FDNIRS) system
(MetaOx, ISS Inc.).22 The estimated BFi using the MD-MW
DCS method was compared with the BFi calculated using
the FDNIRS optical properties at corresponding wavelengths.
Interpolations based on the phantom spectral wavelength
dependence were used for the optical properties at 850 nm.
The FDNIRS multidistance method achieved with a combina-
tion of different detectors requires calibration to correct for
differences in coupling, gain, and fiber transmission of the
detectors and this is done with a solid phantom of known optical
properties.23 Our DCS MD-MW method requires a similar cal-
ibration of the light intensity to estimate μeff , but because of
speckle noise in a solid phantom, it is preferable to use a liquid
phantom as a reference in which the speckle intensity rapidly
fluctuates and thus we measure the true average intensity
with a short temporal average. In fact, DCS measures a single
speckle and must average over longer time than the speckle fluc-
tuation time to estimate the average intensity, while NIRS uses
larger detection fibers to average over thousands of speckles and
thus measures the average intensity directly. Therefore, DCS
intensity was calibrated in the liquid phantom on the first
titration, using the optical properties recovered by FDNIRS.
We verified the consistency of the data when calibrating on
the last titration. The DCS and FDNIRS optical probes were
immerged in the solution on opposite sides of the beaker
container, far enough to avoid cross talk and allow for simulta-
neous acquisition. Both probes had the same source–detector
separations (15, 20, 25, and 30 mm).
3 System Description
A block diagram of the MD-MW DCS system is shown in
Fig. 1: it makes use of three long coherence lasers at three differ-
ent wavelengths in the near-infrared spectral range and eight sin-
gle-photon detectors to collect light at multiple distances. The
lasers are driven by custom circuitry and the output light is
delivered to the tissue through fiber optics to a source location
in the optical probe. The light propagated through the tissue is
collected by single-mode fibers located at different distances in
the optical probe and delivered to the single-photon detectors.
The detector’s outputs are sent to a custom-built field-program-
mable gate array (FPGA)-based correlator board. Four analog
channels are used to record physiological signals. Finally,
a USB 3.0 controller is used to transfer DCS and auxiliary
data to a remote PC.
3.1 Operation Principle
Standard DCS systems use one long coherence length laser
operated in CW mode and continuously detect the light at
the detector. Multiple detectors are typically used in the same
location to average autocorrelation functions and improve sig-
nal-to-noise ratio (SNR). In our approach, we need to use three
or more lasers at different wavelengths and multiple detectors at
different distances. To minimize costs and avoid cross talk
between wavelengths, we use a temporal multiplexing approach
for turning laser sources on and off in sequence. This approach
is intrinsically cross talk free, minimizes the number of detectors
needed by employing the same detector for the different colors,
and minimizes light losses since it does not require the use of
filters to block different wavelengths. The only drawback is the
longer measurement time increased by a factor proportional to
the number of wavelengths measured. For this approach, we
designed and built a laser driver able to provide a stable current
to the lasers and to rapidly multiplex the three colors.
We also developed a correlator board that provides the
multiplexing signals and performs autocorrelation functions
synchronized to each wavelength.
3.2 Laser Selection and Driver Circuitry
To implement the temporal multiplexing approach for providing
multiwavelengths to the tissue, it is necessary to be able to
Fig. 1 Block diagram of the MD-MW DCS system: three long coher-
ence length lasers at different wavelengths are driven by custom elec-
tronics. Eight SPADs collect the light after it propagates through the
tissue, and their output signals are sent to a custom-built FPGA-based
correlator board. Four analog channels allow for the recording of
physiological signals and to evaluate their relationship with the
DCS signals.
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quickly enable/disable the DCS light sources. We selected the
monolithic distributed Bragg reflector (DBR) lasers at 767, 808,
and 852 nm (PHxxxDBR series, by Photodigm Inc.). These
lasers have a coherence length of tens of meters, a maximum
optical power higher than 100 mW when operated in CW,
and a subnanosecond turn on/off time that allows also pulsed
mode operation.24 Each laser is packaged with a thermoelectric
cooler (TEC) to keep a stable temperature for improving the
laser coherence length.
Figure 2 shows a schematic of the custom-built laser driver
based on an ultrastable low-noise current generator capable of
providing to the laser a current configurable between 0 and
500 mA. The driver core is basically a standard current genera-
tor,25 composed of a PMOS transistor able to provide the current
set by the sense resistor (RS) through a digital set point (VS) and
an operational amplifier to provide a stable negative feedback. To
achieve a long coherence length, we carefully designed the cur-
rent generator selecting low-noise low-drift components, filtering
the supply rails, and minimizing the set point disturbances.26
In particular, the 5 Ω sense resistor (Z Series Vishay Foil
Resistors, by Vishay) has a 0.05% tolerance and a 0.05 ppm∕°C
drift, and the operational amplifier (AD8675, by Analog
Devices Inc.) has a 0.2 μV∕°C drift and only a 2.8 nV∕
p
Hz
noise spectral density. The digital set point is provided by a
16-bit digital-to-analog converter (DAC) with a 0.05 ppm∕°C
drift and an 11.8 nV∕
p
Hz noise spectral density (AD5541A,
by Analog Devices Inc.). The DAC is powered between the
laser supply (VDD) and VDD − VREF, where VREF is a 2.5 V pre-
cise voltage reference (VRE3025JS, by Apex Microtechnology
Inc.), to minimize the effect of noise and disturbances on VDD.
When the set point is configured as VS ¼ VDD, the voltage drop
over RS (given by VDD − VS) is 0, resulting in no current flow-
ing into the laser, while setting VS ¼ VDD − VREF, the voltage
drop over RS is VREF, resulting in the maximum current of
VREF∕RS ¼ 500 mA flowing into the laser. The current gener-
ator is also isolated and its power supplies are properly filtered to
further minimize noise and disturbances.
A microcontroller unit (MCU) (ATMEGA2561, by Atmel
Corp.) handles the current settings, the temperature of the
laser through a TEC controller (1MD03-024-04/1, by RMT
Ltd.), and the communication to the system. There is also a
precise 18-bit ADC (analog-to-digital converter) (AD7690,
by Analog Devices Inc.) to monitor the current generator and
to allow the implementation of a digital control loop. A fast en-
able/disable logic allows the MCU or an external signal to turn
on/off the laser in <100 ns. In this way, the MCU can promptly
turn off the laser in case of current generator malfunctioning or
the correlator board can provide a signal for fast-multiplexing of
the light source.
Finally, simple optics focuses the light into the fiber to con-
nect to the optical probe. An aspheric lens (A375TM-B, by
Thorlabs Inc.) collimates the free-space laser’s output and the
light passes through an optical isolator (IO-3D-XXX-VLP
series, by Thorlabs Inc.) to prevent laser damage due to back
reflections. Then, a FiberPort collimator (PAF-X-15-PC-B, by
Thorlabs Inc.) focuses the light into the fiber.
3.3 Optical Probe
Taking advantage of the single-mode fiber requirement for DCS
detectors, we built an ultralight, low-profile, flexible optical
probe that easily attaches to the head. To allow for a low
probe profile, we use optical prisms in a rubber-like 3-D printed
probe head to optimize flexibility and contact with the tissue.
Both fibers and prisms are inserted into the probe head,
where they are glued with a two-component, medical-grade
epoxy featuring very low viscosity and excellent optical-
mechanical properties. The first 10 cm of the fibers are protected
only by the black plastic coating (125 μm diameter) to maximize
flexibility and minimize weight. After that the fibers are com-
bined inside a protective jacket that facilitates handling and safe-
guards them from possible damage. The resulting probe is
shown in Fig. 3. Each laser source is coupled to a 100 μmmulti-
mode fiber (numerical aperature ¼ 0.39) and attached to the
same spot at the optical probe. At the probe end, the light is
expanded to a larger area by bonding a 40 deg holographic dif-
fuser between the source fibers and a 5.5 mm prism. The com-
bination of the diffuser and the prism increases the angle of the
incident light and minimizes the losses due to backscatter. The
light is homogenously spread at the surface of the probe over a
5.5 mm diameter spot. This allows us to use higher optical
power (up to 50 mW, resulting in 2.1 mW∕mm2) while remain-
ing within the American National Standards Institute (ANSI)
maximum permissible exposure of skin to laser radiation:
between 2.6 and 4 mW∕mm2 in the 760 to 850 nm range, as
reported in the ANSI Standard Z136.1-1993 Table. Each detec-
tor is coupled to a 4.4 μm single-mode fiber to enable detection
of single speckles. The detector fibers at the probe end are glued
Fig. 2 Simplified architecture of laser driver. A current generator is
capable of providing to the laser a current between 0 and 500 mA.
The generator is isolated and its power supplies are properly filtered
for minimizing noise and disturbances. The laser package hosts a
TEC to keep a stable temperature for improving the light coherence.
A MCU handles the current settings, the temperature of the laser
through a TEC controller, and the communication to the system.
A fast enable/disable logic allows laser turn on/off for safety reason
or for multiplexing the light source.
Fig. 3 Picture of the DCS probe that includes eight detector fibers
distributed in four locations spaced 15 to 30 mm from the source
that comprises three source wavelengths. More detection fibers
are utilized at longer distances to improve SNR. We offer this and
other probe solution to researchers through a nonprofit organization,
neuluce.org.
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to 3 mm prisms at different distances from the source. Since
the intensity of the detected light exponentially decreases with
distance, for longer distances we use multiple detector fibers
coupled to the same prism to improve the SNR.27
3.4 Detectors
The light collected at the probe is sent to single-photon ava-
lanche diode (SPAD) sensors able to detect light with single-
photon sensitivity. Fast photon counting is required to measure
the autocorrelation function. Key aspects to consider in the
selection of these detectors are the photon detection efficiency
(PDE) to maximize the detection of the collected light, the dark
count rate (DCR) to optimize the SNR, and the afterpulsing
probability and the linear relationship between input light
and output count rate to minimize distortions when computing
the DCS correlation curve.
The detectors employed (SPCM-850-14-FC, by Excelitas
Technologies) have a PDE higher than 64% at 767 nm and
higher than 54% at 852 nm. These detectors also have a low
dead time (20 ns), resulting in an up to 40 Mcps count rate,
allowing for a high SNR thanks to a low DCR, which is
<100 cps. The afterpulsing probability is <3% and the detectors
provide a linear relationship between input light and output
count rate for up to 200 kcps, while at 1 Mcps there is a 2%
distortion. Further characterization is necessary to determine
the maximum conversion rate that guarantees a negligible dis-
tortion in the autocorrelation curve.
3.5 Correlator Board
The last main block of this system is a custom-built correlator
board, shown in Fig. 4. The correlator is based on an FPGA
device that also hosts eight fast-comparators to translate the sin-
gle-photon detector outputs to a proper pulse for the FPGA and
four analog channels to record analog traces. The FPGA time-
tags each detected photon with an arrival time, by means of a
counter locked to a 150 MHz clock, used as the time base. For
maximum flexibility in the analysis, time gating and autocorre-
lations are currently not implemented in the FPGA, but are
instead performed by software28,29 implementing a multitau
scheme, after the data are transferred through a USB 3.0 inter-
face. This allows us to select the integration time in postprocess-
ing, based on the measurement SNR. Because the acquisition
rate is not limited by the software, we can quickly calculate
autocorrelation functions (at a rate >100 Hz), resulting in
blood flow measurements with better than 10 ms resolution.
This feature allows us to measure fast blood flow dynamics,
which enable better physiological noise filtering and quantifica-
tion of additional parameters.30
The correlator board also handles the light source multiplex-
ing and configures the laser currents to provide the same output
power at each wavelength by setting the right driver current,
since the output power versus current curve is different for
each laser. Finally, by controlling the light multiplexing, the cor-
relator board also tags the photons at different wavelengths to
guide the analysis.
4 Results
A full characterization of the system was made by testing both
the main components and the multidistance multiwavelength
method with tissue-like phantoms experiments.
4.1 Detection and Correlator Performance
The detector performance has a significant impact on the quality
of the DCS measurements. First, we verified the low detection
noise and confirmed a DCR of 80 to 100 cps for all eight
detectors. Then, we tested the g2 computation by performing
measurements with a microsphere liquid phantom using our
808 nm DBR laser. We adjusted the light intensity to get a
count rate of 200 kcps to operate the detector in the linear
region. The resulting acquired normalized intensity autocorrela-
tion function, g2, and its postprocessing fit are shown in
Fig. 5(a). We verified that the estimated BFi matched the micro-
sphere proprieties with a low fitting error, computed as the
squared norm of the fitting residual divided by the number of
τ values. Finally, we characterized the potential impact of the
nonlinearity of the detector at high count rates (above
200 kcps) on the autocorrelation function to find the maximum
count rate able to guarantee a negligible distortion in the
g2 curve.
In DCS measurements, the SNR increases with the number
of photons used to compute a g2 curve. Therefore, by keeping a
constant integration time, a higher detection count rate results in
higher SNR of the autocorrelation function. The nonlinearity of
the detector at high count rates results in a distortion of the g2
curve decay. Hence, we increased the light intensity, resulting in
count rate between 50 kcps to 1 Mcps and computed the g2
curves using the same amount of photons (5 million) to get
the same SNR and evaluate only the distortion effect. In
Fig. 5(b), we report the fitting error versus the detector count
rate. The error, computed using the cost function (simplified
version of Eq. (10), with γ ¼ 0 and fitting only over τ), is con-
stant for count rates up to 400 kcps and then rapidly increases
an order of magnitude at 1 Mcps. To minimize distortion, the
resulting optimal device operation is for a count rate no higher
than 400 kcps.
4.2 Laser Stability and Coherence
To successfully perform DCS measurements, stable long coher-
ence length sources are required. We first verified the stability of
our custom laser driver by measuring the current using a low-
drift sense resistor (Z Series Vishay Foil Resistors, by Vishay) as
load and then acquiring its potential difference with a 6½ digit
resolution digital multimeter (34401A, by Agilent). To achieve
the maximum resolution of this multimeter, we acquired the
Fig. 4 Block diagram of the correlator board. An FPGA time-tags the
detected photons using a 150 MHz clock. This allows for performing
real-time autocorrelation functions. The board also handles the laser
drivers and it acquires four analog channels for recording physiologi-
cal signals (i.e., blood pressure, ECG, etc.). A USB 3.0 controller
transfers all data to a PC.
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voltage across the resistor with a 2 sps rate for 12 h, at room
temperature (between 22°C and 26°C). The current is very sta-
ble, as shown in Fig. 6(a), without temperature drifting, thanks
to the very low drift electronic components employed. In fact,
for current set to 134.9 mA, we measured an average current of
134.9094 mA with a 562 nA root mean square standard
deviation, resulting in less than 5 ppm variance.
To test the coherence of the three DBR lasers, we performed
a DCS measurement on a liquid phantom, with a fixed source–
detector distance of 25 mm, and comparing the three DBR lasers
with results from a CrystaLaser laser at 785 nm (CL-2000 diode
pumped crystal, by CrystaLaser) typically used for DCS mea-
surements. The autocorrelation functions (g2) obtained with the
four lasers are shown in Fig. 6(b), resulting in a β close to the
theoretical maximum value of 0.5, for all lasers. The differences
in decays are due to the different optical proprieties of the liquid
phantom at the four wavelengths. This measurement proves that
the coherence length of the DBR lasers is sufficient for DCS
measurements.
4.3 Laser Switching Performance
Wemeasured the behavior of the DBR lasers when turning them
on and off in rapid sequence to test whether the coherence length
decreases with fast switching. We acquired data on a micro-
sphere phantom and fed a 1 Hz trigger signal with 50% duty
cycle to the 808 nm DBR laser to turn it on and off. We acquired
the trigger signal through the analog channel to synchronize the
g2 curves with the laser turn-on times. We computed g2 curves
and light intensity every 1 ms, from 20 ms before the detected
rising edge to 520 ms after it. Since every 1 ms step has a limited
number of photons (i.e., 200 photons for 200 kcps) resulting in a
very noisy g2 curve, we averaged the intensity and the g2 curves
over 900 periods. The coherence is evaluated as the β of the
fitted autocorrelation curves. The behavior of the 808 nm
laser is shown in Fig. 7, where both coherence and intensity
are stable within 1 ms after the laser turn-on time, with a
beta of 0.43 0.02 (mean value standard deviation com-
puted in the 900 periods) and a count rate of 196 13 kcps.
Fig. 5 (a) DCS measurement on a microsphere phantom (1 s integration time) and the fitting result. The
computed mean squared displacement of 2.58 × 10−9 cm2∕s is in agreement with the expected value of
2.5 × 10−9 cm2∕s, measured using the gold-standard FDNIRS system. (b) Fitting error versus the detec-
tor count rate obtained by increasing the light intensity and acquiring DCS autocorrelation curves for
16 different count rate levels between 50 kcps and 1 Mcps. For each step, the autocorrelation functions
are computed using the same number of photon (5 million photons).
Fig. 6 Current stability of the laser driver (a) over 12 h with a temperature fluctuation of about 4°C.
Autocorrelation functions (b) of the three DBR laser at 767, 808, and 852 nm, chosen for the system
compared to a 785 nm CrystaLaser laser typically used for DCSmeasurements. The decays are different
due to different optical properties of the sample at different wavelengths. The similar β indicates sufficient
coherence length of the DBR lasers.
Neurophotonics 011015-6 Jan–Mar 2018 • Vol. 5(1)
Tamborini et al.: Development and characterization of a multidistance. . .
Downloaded From: https://www.spiedigitallibrary.org/journals/Neurophotonics on 04 Sep 2019
Terms of Use: https://www.spiedigitallibrary.org/terms-of-use
Similar performances were observed with the other two lasers:
beta of 0.41 0.02 with a 187 12 kcps count rate at 852 nm
and a 0.47 0.03 beta with count rate of 242 17 kcps at
767 nm.
This shows a negligible system warm-up time when the laser
is switched on, allowing us to use a multiplexing time as short
as tens of milliseconds and to rapidly acquire BFi at the three
wavelengths in succession. We also evaluate the impact of the
temporal multiplexing approach on the computation of the g2
curves. Compared to a standard single-wavelength DCS system,
to get BFi with the same acquisition rate with this system, we
need to compute three g2 curves (one per wavelength) in 1∕3 of
the time per wavelength. As described in Ref. 31, the noise of




, where t is the inte-
gration time. However, we could have excess noise as we also
Fig. 7 Measurement of the intensity and the coherence factor (β) of
the light when switching the 808 nm laser with a 1 Hz square wave.
Both intensity and beta are stable within 1 ms of the laser triggering
signal.
×
Fig. 8 (a) Results on liquid phantoms, of absorption titration, (b) scattering titration, and (c) dynamic
titration. Absorption coefficient at 808 nm, scattering coefficient at 808 nm, and blood flow index are
recovered using the FDNIRS (black), the multidistance DCS method (red), and the multidistance and
multiwavelength DCS (green) methods. For both FDNIRS and DCS, we considered source–detector
separations of 15, 20, 25, and 30 mm. *Diffusion titration results are shown at 785 nm due to a failure
of the 808 nm and its manufacture long fixing time which has prevented us to use it for these
measurements.
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want to rapidly multiplex between wavelengths to make the
measurements as nearly simultaneous as possible, but then
integrate across multiplexed states to obtain a better SNR.
The excess noise would arise from incomplete sampling of
the correlation function if we multiplex on time scales approach-
ing the decorrelation time scale. We experimentally verified that
switching the lasers on and off at 25 ms intervals do not further
increase the noise in g2 with respect to CW operation. This was
expected as 25 ms is much longer than the typical 10−5 to 10−4
decay time for our measured correlation functions.
4.4 Phantom Validation
To experimentally demonstrate the robustness of the MD-MW
DCS method, we performed measurements on liquid phantoms
while changing their optical proprieties and simultaneously
fitting for a, b, ink concentration, and BFi. We compared the
results of the MD-MW DCS method with the results obtained
using only the multidistance information (MD DCS) and used
the absorption and scattering measured with the FDNIRS sys-
tem and the derived BFi using these coefficients as the reference
values.32 In Fig. 8 from left to right, we show the absorption,
scattering, and dynamic titrations, and from top to bottom,
we show the absorption coefficient, the reduced scattering coef-
ficient, and the mean square displacement of the solution as a
function of titration level. For the absorption titration, the com-
puted absorption coefficients recovered with our MW-MD DCS
approach linearly increase with the Ink concentration and are in
good agreement with the FDNIRS values with a maximum
deviation of about 25%. The estimated reduced scattering co-
efficient and BFi remain relatively constant during the absorp-
tion titration, revealing small cross talk with changes in absorp-
tion. For the scattering titration, the computed reduced scattering
coefficients obtained with our method linearly increases with
Intralipid concentration, in agreement with the FDNIRS results.
The estimated absorption coefficient using the MD-MW DCS
method remains relatively constant, while the BFi shows a slight
decrease with increased scattering on both FDNIRS and MD-
MW DCS. For the dynamic titration, the computed mean square
displacement (BFi) increases with the stirrer level and the recov-
ered absorption and scattering coefficients remain relatively
constant during the titration. For all titrations, the parameters
derived with the MD-MW DCS method are in good agreement
with the parameters computed using the FDNIRS, with a maxi-
mum difference of about 25%. The only exception is during stir-
rer level 3 for which the absorption coefficient differs by about
33%, and the reduced scattering coefficient differs by about 66%
between the two modalities. By only using the multidistance
DCS information (red traces), we consistently obtained large
deviations with the FDNIRS method, with differences in all
computed parameters of up to 100% to 400%. These phantom
measurements demonstrate that by adding the measures of
intensity at multiple distances and DCS at multiple wavelengths,
we add unique information that improves the ability to estimate
μa, μ 0s , and BFi, reaching a performance close to the state-of-the-
art FDNIRS-DCS method.
5 Discussion and Conclusion
We designed and characterized a stand-alone multidistance mul-
tiwavelength DCS system able to simultaneously measure tissue
optical proprieties and blood flow index, by taking advantage of
both the light intensity decay over source–detector separation
and the autocorrelation function at three wavelengths.
We demonstrated the capabilities of the MD-MW DCS
method by measuring the optical properties and dynamics of
liquid phantoms. We compared the results with simultaneous
measurements obtained by a commercial FDNIRS system
(MetaOx, ISS Inc.).23 The absolute values recovered are in
agreement with the “gold-standard” FDNIRS-DCS method.
The variation of absorption and scattering coefficients with
Ink and Intralipid concentration displays excellent linearity.
During the scattering titration, the cross talk into absorption
is negligible, and the slight decrease in BFi may be due to an
increase in viscosity with increasing Intralipid concentration, as
BFi also decrease when using the optical properties derived from
FDNIRS, to computeBFi. Also, when increasing the stirrer level
to increase BFi the recovered values are in agreement with the
commercial FDNIRS values, with some cross talk with the scat-
tering coefficient at high stirrer levels. The next step will be to
validate the method in vivo, with both animals and humans.
We have shown that this method is less prone to noise than a
previous DCS approach based on multidistance measurements
alone.10 This is because the additional measures of intensity and
g2 at different wavelengths provide sufficient information to
uniquely recover the unknowns (BFi, a, b, and chromophore
concentrations). Multiple wavelengths have been previously
used for DCS measurements33 but only to recover hemoglobin
oxygenation from the light intensities, not to improve the quan-
titative estimate of BFi by fitting g2 at the multiple wavelengths
simultaneously.
The minimum number of source–detector separations to
implement the multidistance DCS method could be two, in
ideal conditions (e.g., on homogeneous phantoms and in simu-
lations). When considering an in vivo measurement, it is not
sufficient to rely on only two separations, due to random and
systematic errors and the nonhomogenous tissue properties.
We have extensive experience with the FDNIRS multidistance
method and demonstrated that by considering three or more sep-
arations we are able to remove poor-quality data, improving the
robustness of in vivo measurements.34,35 The same conclusion
should apply to DCS or CWNIRS multidistance approaches.
For this reason, in this DCS system, we increased the number
of source–detector separations to four to verify and determine
the linearity of the light intensity over distance. As a drawback,
the additional source–detector separations result in a higher
number of detectors and an increase in the cost of the system.
A similar argument can be made about the number of
required wavelengths. By increasing the number of wave-
lengths, we provide additional information to help the fitting
algorithm to converge to a unique solution, and to minimize
the cross talk between BFi and reduced scattering coefficient
in the autocorrelation function. Limitation in increasing the
number of wavelengths is due to the increasing cost of the sys-
tem and the low number of coherent lasers available in the near-
infrared spectral range. We focused our selection based on the
commercially available long coherence laser, the detector effi-
ciency, the hemoglobin spectra, the complexity of the fitting
algorithm, and minimizing the number of lasers to reduce the
cost. In the liquid phantom experiments, we ran our algorithm
using from one to four wavelengths. As shown in Fig. 8, one
wavelength is not enough to properly recover the parameter,
resulting in errors >100%. Using two wavelengths partially
reduce these errors to 75%. As shown in Fig. 8, using three
wavelengths we obtained consistent improvements. We also
verified negligible improvement by adding a fourth wavelength
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during the absorption and scattering titrations. For these reasons,
we consider three wavelengths to be the optimal compromise
between performance and cost with this number of unknowns.
Our algorithm minimizes the cost function by fitting not only
the measured autocorrelation function, but also the effective
attenuation coefficient. The contribution of this last term is
determined by γ [Eq. (10)]. In our analysis, a value of γ between
0.05 and 0.50 results in <10% variance of the results. The results
presented in Fig. 8 are obtained using γ ¼ 0.30, providing a
good contribution of the μeff data to the cost function.
With respect to current combined NIRS and DCS systems,
using only DCS there are advantages in reducing cost, size, and
complexity of the device. For instance, typical NIRS-DCS sys-
tems consist of a DCS component and either an FDNIRS23 or a
time-resolved spectroscopy (TRS) component.36 The NIRS and
DCS components do not share either sources or detectors, which
leads to a more complex system architecture and increased costs
and size of the combined system with respect to a stand-alone
system. We have recently proposed a TD-DCS system24 that
uses a pulsed laser and a photon counting detector to quantify
both optical properties and blood flow. While the method is
very appealing, and will in the future be the best solution,
it currently requires very sophisticated components (custom
high-power laser, red-enhanced SPAD detectors, and high-per-
formance time-correlated single-photon counting electronics),
which does not necessarily reduce costs. Combining DCS
with CWNIRS, while simple and inexpensive, does not help
with the recovery of the reduced scattering coefficients. As we
showed here in experiments, acquiring autocorrelation functions
at only one wavelength is not sufficient to separate scattering
from blood flow. Without the knowledge of the scattering, DCS
can only quantify relative changes in BFi.
Another advantage of stand-alone DCS resides in the ability
to use very light, flexible, and small optical probes as the patient
interface. In fact, the DCS requirement of a single-mode detec-
tor fiber (4.4 μm diameter) to collect light from single speckles,
instead of the large NIRS fiber bundles, allows us to develop
small probes as shown in Fig. 3. This represents a strong advan-
tage for continuous monitoring, since lighter and more flexible
fibers and probes can be more easily attached, reducing motion
artifact and providing more comfort for the patient. In fact, the
fibers we use have high strength (≥200 kpsi) and a very high
bending radius (≥6 mm), which allow us to keep the probe
in place without forcing it in position. The thin coating and
jacket used on the fibers at the probe interface may be prone
to damage if mishandled. Still, we do not see this as a major
problem since the optical probe needs to be treated with care in
any case, as it contains polished fibers and optics and needs to be
attached to the patient.
The proposed MD-MW approach to estimate the optical
properties from DCS alone is based on the same assumptions
used for the multidistance multiwavelength FDNIRS
method,22,37 i.e., the investigated tissue is assumed to be homo-
geneous. For the FDNIRS, this assumption holds in the case of
separations >10 mm and superficial layers thinner than 5 to
6 mm, as demonstrated both experimentally in phantoms,38
and with Monte Carlo simulations in segmented MRI children
head models.39 In fact, the MD-MW FDNIRS method is con-
sidered by many the gold standard for cerebral oximetry.32
In the future, we expect these depth sensitivity results to be
replicated for this DCS method. In fact, the work of Selb
et al.40 indicates that the depth sensitivity of DCS is great
than CW NIRS because the early part of the decay of the auto-
correlation function is driven by longer path-length photons than
the average path length of CW NIRS photons. We expect this
method to work best in infants where the homogeneous medium
assumption works well. In adults, even with the greater depth
sensitivity of DCS, layered models need to be applied to obtain
quantitative values. Also in adults, larger source–detector sep-
arations will be necessary to estimate optical properties of
the cerebral cortex. In this case, we can adopt different strategies
to increase SNR at the larger distances. For instance, we can
increase the integration time for the recovery of the scattering
coefficient. The scattering coefficient changes slowly over
time. It is thus sufficient to measure it every 1 to 2 min, and
assume it is constant during these periods while fitting for
BFi and hemoglobin concentrations at a much faster rate. We
can add additional lasers to increase the number of independent
measurements in the MD-MW DCS fitting procedure. We
can also add channels at larger separations with larger detector
fibers for additional intensity measurements, since sensitivity to
deeper layers is lower for intensity than for g2.
40
In conclusion, we have presented a new stand-alone DCS
system that employs lasers at multiple wavelengths and multiple
detector channels to recover both optical properties and blood
flow of biological tissues. We have characterized the system
and demonstrated initial feasibility of the method.
Disclosures
The authors hold patents on the technology used in this paper.
Acknowledgments
We thank Zachary Starkweather for building the optical probes,
Ryan Stocking for help assembling the instrument, and Jason
Sutin for scientific discussion. This research was supported
by NIH R01GM116177, R21NS093259, and R21NS094828
and the Baby Alex Foundation.
References
1. R. C. Mesquita et al., “Direct measurement of tissue blood flow and
metabolism with diffuse optics,” Philos. Trans. R. Soc. London A
369(1955), 4390–4406 (2011).
2. T. Durduran and A. G. Yodh, “Diffuse correlation spectroscopy for
non-invasive, micro-vascular cerebral blood flow measurement,”
NeuroImage 85(Part 1), 51–63 (2013).
3. E. M. Buckley et al., “Diffuse correlation spectroscopy for measurement
of cerebral blood flow: future prospects,” Neurophotonics 1(1), 011009
(2014).
4. D. A. Boas and A. G. Yodh, “Spatially varying dynamical properties of
turbid media probed with diffusing temporal light correlation,” J. Opt.
Soc. Am. A 14(1), 192–215 (1997).
5. C. Cheung et al., “In vivo cerebrovascular measurement combining
diffuse near-infrared absorption and correlation spectroscopies,” Phys.
Med. Biol. 46(8), 2053–2065 (2001).
6. D. A. Boas, L. E. Campbell, and A. G. Yodh, “Scattering and imaging
with diffusing temporal field correlations,” Phys. Rev. Lett. 75(9), 1855–
1858 (1995).
7. L. Dong et al., “Simultaneously extracting multiple parameters via
fitting one single autocorrelation function curve in diffuse correlation
spectroscopy,” IEEE Trans. Biomed. Eng. 60(2), 361–368 (2013).
8. T. Durduran et al., “Diffuse optics for tissue monitoring and tomogra-
phy,” Rep. Prog. Phys. 73(7), 076701 (2010).
9. N. Roche-Labarbe et al., “Noninvasive optical measures of CBV, StO2,
CBF index, and rCMRO2 in human premature neonates’ brains in the
first six weeks of life,” Hum. Brain Mapp. 31(3), 341–352 (2010).
Neurophotonics 011015-9 Jan–Mar 2018 • Vol. 5(1)
Tamborini et al.: Development and characterization of a multidistance. . .
Downloaded From: https://www.spiedigitallibrary.org/journals/Neurophotonics on 04 Sep 2019
Terms of Use: https://www.spiedigitallibrary.org/terms-of-use
10. P. Farzam and T. Durduran, “Multidistance diffuse correlation spectros-
copy for simultaneous estimation of blood flow index and optical prop-
erties,” J. Biomed. Opt. 20(5), 055001 (2015).
11. D. Boas et al., “Establishing the diffuse correlation spectroscopy signal
relationship with blood flow,” Neurophotonics 3(3), 031412 (2016).
12. P. A. Lemieux and D. J. Durian, “Investigating non-Gaussian scattering
processes by using nth-order intensity correlation functions,” J. Opt.
Soc. Am. A 16, 1651–1664 (1999).
13. L. He et al., “Using optical fibers with different modes to improve the
signal-to-noise ratio of diffuse correlation spectroscopy flow-oximeter
measurements,” J. Biomed. Opt. 18(3), 037001 (2013).
14. H. J. van Staveren et al., “Light scattering in intralipid-10% in the wave-
length range of 400–1100 nm,” Appl. Opt. 30(31), 4507 (1991).
15. J. R. Mourant et al., “Mechanisms of light scattering from biological
cells relevant to noninvasive optical-tissue diagnostics,” Appl. Opt.
37(16), 3586–3593 (1998).
16. X. Wang et al., “Approximation of Mie scattering parameters in near-
infrared tomography of normal breast tissue in vivo,” J. Biomed. Opt.
10(5), 051704 (2005).
17. S. L. Jacques and B. W. Pogue, “Tutorial on diffuse light transport,”
J. Biomed. Opt. 13(4), 041302 (2008).
18. S. L. Jacques, “Optical properties of biological tissues: a review,” Phys.
Med. Biol. 58(11), R37 (2013).
19. S. Prahl, “Optical absorption of hemoglobin,” http://omlc.ogi.edu/
spectra (2013).
20. D. R. White, H. Q. Woodard, and S. M. Hammond, “Average soft-tissue
and bone models for use in radiation dosimetry,” Br. Inst. Radiol.
60(717), 907–913 (1987).
21. D. R. White et al., “The composition of body tissues. (II) Fetus to young
adult,” Br. Inst. Radiol. 64(758), 149–159 (1990).
22. S. Fantini et al., “Frequency-domain multichannel optical detector for
noninvasive tissue spectroscopy and oximetry,” Opt. Eng. 34(1), 32–42
(1995).
23. S. A. Carp et al., “Combined multi-distance frequency domain and dif-
fuse correlation spectroscopy system with simultaneous data acquisition
and real-time analysis,” Biomed. Opt. Express 8(9), 3993–4006 (2017).
24. J. Sutin et al., “Time-domain diffuse correlation spectroscopy,” Optica
3, 1006–1013 (2016).
25. P. Horowitz and W. Hill, “Operational amplifier,” in The Art of
Electronics, 3rd ed., Cambridge University Press, Cambridge, England
(2015).
26. C. J. Erickson et al., “An ultrahigh stability, low-noise laser current
driver with digital control,” Rev. Sci. Instrum. 79, 073107 (2008).
27. G. Dietsche et al., “Fiber-based multispeckle detection for time-resolved
diffusing-wave spectroscopy: characterization and application to blood
flow detection in deep tissue,” Appl. Opt. 46(35), 8506 (2007).
28. D. Wang et al., “Fast blood flow monitoring in deep tissues with real-
time software correlators,” Biomed. Opt. Express 7(3), 776–797 (2016).
29. J. Dong et al., “Diffuse correlation spectroscopy with a fast Fourier
transform-based software autocorrelator,” J. Biomed. Opt. 17(9),
097004 (2012).
30. P. Farzam et al., “Fast diffuse correlation spectroscopy for non-invasive
measurement of intracranial pressure,”Proc. SPIE 1005, 100500U (2017).
31. C. Zhou et al., “Diffuse optical correlation tomography of cerebral
blood flow during cortical spreading depression in rat brain,” Opt.
Express 14(3), 1125–1144 (2006).
32. S. Kleiser et al., “Comparison of tissue oximeters on a liquid phantom
with adjustable optical properties,” Biomed. Opt. Express 7(8), 2973–
2992 (2016).
33. Y. Shang et al., “Portable optical tissue flow oximeter based on diffuse
correlation spectroscopy,” Opt. Lett. 34(22), 3556–3558 (2009).
34. M. A. Franceschini et al., “Assessment of infant brain development with
frequency-domain near-infrared spectroscopy,” Pediatr. Res. 61(5),
546–551 (2007).
35. P. Y. Lin et al., “Non-invasive optical measurement of cerebral
metabolism and hemodynamics in infants,” J. Visualized Exp. 73,
4379 (2013).
36. U. M. Weigel et al., “The BabyLux project—an optical neuro-monitor
of cerebral oxygen metabolism and blood flow for neonatology,” in
Biomedical Optics, p. JM3A.30 (2016).
37. S. Fantini, M. A. Franceschini, and E. Gratton, “Semi-infinite-geometry
boundary problem for light migration in highly scattering media: a fre-
quency-domain study in the diffusion approximation,” J. Opt. Soc. Am.
B 11(10), 2128–2138 (1994).
38. M. A. Franceschini et al., “Influence of a superficial layer in the quan-
titative spectroscopic study of strongly scattering media,” Appl. Opt.
37(31), 7447–7458 (1998).
39. M. Dehaes et al., “Assessment of the frequency-domain multi-distance
method to evaluate the brain optical properties: Monte Carlo simulations
from neonate to adult,” Biomed. Opt. Express 2(3), 552–567 (2011).
40. J. Selb et al., “Sensitivity of near-infrared spectroscopy and diffuse cor-
relation spectroscopy to brain hemodynamics: simulations and experi-
mental findings during hypercapnia,” Neurophotonics 1(1), 015005
(2014).
Davide Tamborini is a research fellow in the optics division of the
Martinos Center for Biomedical Imaging at Massachusetts General
Hospital and Harvard Medical School. He received his MSc cum
laude in electronic engineering and PhD in information and commu-
nication technology at the Politecnico di Milano, Milano, Italy, in 2012
and 2015, respectively. His current research interests include con-
ceiving and developing near-infrared spectroscopy instrumentations
for biomedical diagnosis.
Parisa Farzam is a research fellow at Martinos Center for Biomedical
Imaging at Massachusetts General Hospital, Harvard Medical School.
She received her PhD in biomedical photonics from ICFO-The
Institute of Photonics Sciences, Spain. Her research interests include
developing novel diffuse optical instrumentation, algorithms, and pro-
tocols, and applying them for preclinical and clinical investigations.
Bernhard Zimmermann is a PhD candidate in the optics division of
the Martinos Center for Biomedical Imaging at Massachusetts
General Hospital and at the Department of Electrical Engineering
and Computer Science at the Massachusetts Institute of Technology.
He received his MSc ETH in electrical engineering and information
technology from Swiss Federal Institute of Technology in Zurich.
His research interests include the design and development of diffuse
optics instruments for brain monitoring and cancer detection.
Kuan-Cheng Wu is a visiting student in Martinos Center for
Biomedical Imaging, Massachusetts General Hospital. He is a gradu-
ate student from the Institute of Biomedical Engineering, National
Cheng Kung University, Taiwan. He has been working on near-infra-
red spectroscopy since the first year in college. He then joined the
optics division in Martinos in 2015, and started working on diffuse
correlation spectroscopy.
David A. Boas is the director of Boston University Neurophotonics
Center, and a professor of Biomedical Engineering. He received
his BS degree in physics at RPI and his PhD in physics at the
University of Pennsylvania. He is the founding president of the Society
for Functional Near-Infrared Spectroscopy, founding editor in-chief of
Neurophotonics, and the recipient of the 2016 Britton Chance Award
in biomedical optics.
Maria Angela Franceschini is a faculty member in the optics division
of the Martinos Center for biomedical imaging at Massachusetts
General Hospital and an associate professor at Harvard Medical
School. Her research interests include the development and applica-
tion of noninvasive optical techniques to studies of the human brain.
She is a pioneer in the field of near-infrared spectroscopy (NIRS) and
has made substantial contributions to the modeling, testing, and clini-
cal and neuroscience translation of NIRS and diffuse correlation
spectroscopy.
Neurophotonics 011015-10 Jan–Mar 2018 • Vol. 5(1)
Tamborini et al.: Development and characterization of a multidistance. . .
Downloaded From: https://www.spiedigitallibrary.org/journals/Neurophotonics on 04 Sep 2019
Terms of Use: https://www.spiedigitallibrary.org/terms-of-use
